151 related articles for article (PubMed ID: 19196511)
21. Blockade of the chemokine receptor CXCR2 ameliorates adjuvant-induced arthritis in rats.
Barsante MM; Cunha TM; Allegretti M; Cattani F; Policani F; Bizzarri C; Tafuri WL; Poole S; Cunha FQ; Bertini R; Teixeira MM
Br J Pharmacol; 2008 Mar; 153(5):992-1002. PubMed ID: 17891165
[TBL] [Abstract][Full Text] [Related]
22. ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets.
Bizzarri C; Beccari AR; Bertini R; Cavicchia MR; Giorgini S; Allegretti M
Pharmacol Ther; 2006 Oct; 112(1):139-49. PubMed ID: 16720046
[TBL] [Abstract][Full Text] [Related]
23. The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases.
Russo RC; Garcia CC; Teixeira MM; Amaral FA
Expert Rev Clin Immunol; 2014 May; 10(5):593-619. PubMed ID: 24678812
[TBL] [Abstract][Full Text] [Related]
24. Hit-to-Lead studies: the discovery of potent, orally bioavailable thiazolopyrimidine CXCR2 receptor antagonists.
Baxter A; Cooper A; Kinchin E; Moakes K; Unitt J; Wallace A
Bioorg Med Chem Lett; 2006 Feb; 16(4):960-3. PubMed ID: 16297626
[TBL] [Abstract][Full Text] [Related]
25. Receptor binding mode and pharmacological characterization of a potent and selective dual CXCR1/CXCR2 non-competitive allosteric inhibitor.
Bertini R; Barcelos LS; Beccari AR; Cavalieri B; Moriconi A; Bizzarri C; Di Benedetto P; Di Giacinto C; Gloaguen I; Galliera E; Corsi MM; Russo RC; Andrade SP; Cesta MC; Nano G; Aramini A; Cutrin JC; Locati M; Allegretti M; Teixeira MM
Br J Pharmacol; 2012 Jan; 165(2):436-54. PubMed ID: 21718305
[TBL] [Abstract][Full Text] [Related]
26. Small-molecule antagonists for CXCR2 and CXCR1 inhibit human melanoma growth by decreasing tumor cell proliferation, survival, and angiogenesis.
Singh S; Sadanandam A; Nannuru KC; Varney ML; Mayer-Ezell R; Bond R; Singh RK
Clin Cancer Res; 2009 Apr; 15(7):2380-6. PubMed ID: 19293256
[TBL] [Abstract][Full Text] [Related]
27. Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastases.
Varney ML; Singh S; Li A; Mayer-Ezell R; Bond R; Singh RK
Cancer Lett; 2011 Jan; 300(2):180-8. PubMed ID: 21035946
[TBL] [Abstract][Full Text] [Related]
28. Boronic acid-containing aminopyridine- and aminopyrimidinecarboxamide CXCR1/2 antagonists: Optimization of aqueous solubility and oral bioavailability.
Schuler AD; Engles CA; Maeda DY; Quinn MT; Kirpotina LN; Wicomb WN; Mason SN; Auten RL; Zebala JA
Bioorg Med Chem Lett; 2015 Sep; 25(18):3793-7. PubMed ID: 26248802
[TBL] [Abstract][Full Text] [Related]
29. Reversing systemic inflammatory response syndrome with chemokine receptor pepducins.
Kaneider NC; Agarwal A; Leger AJ; Kuliopulos A
Nat Med; 2005 Jun; 11(6):661-5. PubMed ID: 15880119
[TBL] [Abstract][Full Text] [Related]
30. CXCR2 in acute lung injury.
Konrad FM; Reutershan J
Mediators Inflamm; 2012; 2012():740987. PubMed ID: 22719179
[TBL] [Abstract][Full Text] [Related]
31. [The role of CXCR1/2 in shear stress-induced endothelial cell migration].
Sun H; Wei L; Liu X; Zeng Y; Lai Y; Yin H
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Jun; 26(3):512-7. PubMed ID: 19634663
[TBL] [Abstract][Full Text] [Related]
32. The effects of a CXCR1/CXCR2 antagonist on neutrophil migration in mild atopic asthmatic subjects.
Todd CM; Salter BM; Murphy DM; Watson RM; Howie KJ; Milot J; Sadeh J; Boulet LP; O'Byrne PM; Gauvreau GM
Pulm Pharmacol Ther; 2016 Dec; 41():34-39. PubMed ID: 27640067
[TBL] [Abstract][Full Text] [Related]
33. Carboxylic acid bioisosteres acylsulfonamides, acylsulfamides, and sulfonylureas as novel antagonists of the CXCR2 receptor.
Winters MP; Crysler C; Subasinghe N; Ryan D; Leong L; Zhao S; Donatelli R; Yurkow E; Mazzulla M; Boczon L; Manthey CL; Molloy C; Raymond H; Murray L; McAlonan L; Tomczuk B
Bioorg Med Chem Lett; 2008 Mar; 18(6):1926-30. PubMed ID: 18308567
[TBL] [Abstract][Full Text] [Related]
34. The functional significance behind expressing two IL-8 receptor types on PMN.
Stillie R; Farooq SM; Gordon JR; Stadnyk AW
J Leukoc Biol; 2009 Sep; 86(3):529-43. PubMed ID: 19564575
[TBL] [Abstract][Full Text] [Related]
35. Imidazolylpyrimidine based CXCR2 chemokine receptor antagonists.
Ho KK; Auld DS; Bohnstedt AC; Conti P; Dokter W; Erickson S; Feng D; Inglese J; Kingsbury C; Kultgen SG; Liu RQ; Masterson CM; Ohlmeyer M; Rong Y; Rooseboom M; Roughton A; Samama P; Smit MJ; Son E; van der Louw J; Vogel G; Webb M; Wijkmans J; You M
Bioorg Med Chem Lett; 2006 May; 16(10):2724-8. PubMed ID: 16540318
[TBL] [Abstract][Full Text] [Related]
36. At-line coupling of LC-MS to bioaffinity and selectivity assessment for metabolic profiling of ligands towards chemokine receptors CXCR1 and CXCR2.
Mladic M; Scholten DJ; Niessen WM; Somsen GW; Smit MJ; Kool J
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Oct; 1002():42-53. PubMed ID: 26301479
[TBL] [Abstract][Full Text] [Related]
37. Dynamic regulation of CXCR1 and CXCR2 homo- and heterodimers.
Martínez Muñoz L; Lucas P; Navarro G; Checa AI; Franco R; Martínez-A C; Rodríguez-Frade JM; Mellado M
J Immunol; 2009 Dec; 183(11):7337-46. PubMed ID: 19890050
[TBL] [Abstract][Full Text] [Related]
38. Identification and characterization of a new interleukin-8 receptor in bovine species.
Lahouassa H; Rainard P; Caraty A; Riollet C
Mol Immunol; 2008 Feb; 45(4):1153-64. PubMed ID: 17727952
[TBL] [Abstract][Full Text] [Related]
39. Cloning and pharmacological characterization of CXCR1 and CXCR2 from Macaca fascicularis.
Hipkin RW; Deno G; Fine J; Sun Y; Wilburn B; Fan X; Gonsiorek W; Wiekowski MT
J Pharmacol Exp Ther; 2004 Jul; 310(1):291-300. PubMed ID: 15028780
[TBL] [Abstract][Full Text] [Related]
40. The selective CXCR2 antagonist SB272844 blocks interleukin-8 and growth-related oncogene-alpha-mediated inhibition of spontaneous neutrophil apoptosis.
Glynn PC; Henney E; Hall IP
Pulm Pharmacol Ther; 2002; 15(2):103-10. PubMed ID: 12090783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
